Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA, FTC, 30 State AGs Join Forces To Combat Fraudulent Anthrax Products

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission is renewing efforts to track down colloidal silver supplements sold online under a federal and state multi-agency campaign against fraudulent products indicated for anthrax

You may also be interested in...



SARS Prevention, Treatment Claims Inappropriate For Supplements – Industry

Supplement marketers and retailers "should refrain from promoting any dietary supplement" with severe acute respiratory syndrome (SARS) disease claims, according to an April 21 1press release from a coalition of five trade associations

SARS Prevention, Treatment Claims Inappropriate For Supplements – Industry

Supplement marketers and retailers "should refrain from promoting any dietary supplement" with severe acute respiratory syndrome (SARS) disease claims, according to an April 21 1press release from a coalition of five trade associations

SARS Prevention, Treatment Claims Inappropriate For Supplements – Industry

Supplement marketers and retailers "should refrain from promoting any dietary supplement" with severe acute respiratory syndrome (SARS) disease claims, according to an April 21 1press release from a coalition of five trade associations

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS093228

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel